Thank you, Biocom, for having us! Michael Boyne and Greta Wodarcyk enjoyed being part of the panel alongside speakers Alex Loftis, Farhad Parhami, Ph.D., M.B.A., and Franklin Rice. Clinical planning should drive a company’s entire development strategy from day 1️⃣. Success starts with the end…   ​ Read More

📣 Great opportunity for anyone involved in the drug development process. CatalystBio founders, Greta Wodarcyk and Michael Boyne…Read More

🎉 Congratulations to PolarityBio on their BLA submission! The CatalystBio team is proud to have supported PolarityBio on their BLA submission to the U.S. FDA for SkinTE® – a first-in-class autologous cutaneous multicellular therapy targeting diabetic foot ulcers (DFUs). If approved, this would be the…   ​ Read More